Literature DB >> 3399071

Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia.

C L Ludlow1, R F Naunton, S E Sedory, G M Schulz, M Hallett.   

Abstract

Adductor spasmodic dysphonia involves an overadduction of the vocal folds during speech causing uncontrolled voice and pitch breaks and slow, effortful speech. The disorder is resistant to speech therapy and often recurs following initial benefit from unilateral recurrent laryngeal nerve resection. Botulinum toxin injections into multiple sites of the thyroarytenoid muscle on one side were performed in 16 patients. Speech was recorded prior to injection and three times post-injection. Symptoms were measured by two examiners from speech spectrograms without knowledge of speaker identity or recording session. Significant (p less than or equal to 0.03) reductions in pitch and voice breaks, phonatory aperiodicity, and sentence time occurred only when injections resulted in unilateral vocal fold paralysis. Symptoms returned with the restoration of vocal fold movement, 3 months later. Reduction in speed of swallowing without aspiration was reported in 80% of cases. Although speech volume was reduced, there were no instances of aphonia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3399071     DOI: 10.1212/wnl.38.8.1220

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

Review 1.  New approaches in the treatment of the dystonias.

Authors:  N Diederich; C G Goetz; C L Comella
Journal:  Klin Wochenschr       Date:  1990-10-03

2.  Botulinum toxin treatment in spasmodic torticollis.

Authors:  J D Blackie; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

Review 3.  The dystonias.

Authors:  C D Marsden; N P Quinn
Journal:  BMJ       Date:  1990-01-20

Review 4.  Botulinum toxin for cerebral palsy; where are we now?

Authors:  R E Morton; J Hankinson; J Nicholson
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

5.  The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie
Journal:  J Commun Disord       Date:  2005 Sep-Oct       Impact factor: 2.288

Review 6.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

7.  Intrinsic properties of the adult human mylohyoid muscle: neural organization, fiber-type distribution, and myosin heavy chain expression.

Authors:  Min Ren; Liancai Mu
Journal:  Dysphagia       Date:  2005       Impact factor: 3.438

8.  A proposal to extend application of laryngeal electromyography (LEMG)-guided vocal fold injection to treatment of unilateral vocal fold paralysis to enhance clinical popularity of LEMG: response to the paper by G.F. Volk et al.

Authors:  Chen-Chi Wang; Ming-Hong Chang
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-11       Impact factor: 2.503

9.  Oropharyngeal swallowing in craniocervical dystonia.

Authors:  C Ertekin; I Aydogdu; Y Seçil; N Kiylioglu; S Tarlaci; T Ozdemirkiran
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

10.  Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin.

Authors:  A J Lees; N Turjanski; J Rivest; R Whurr; M Lorch; G Brookes
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.